Astrana Health Files 8-K

Ticker: ASTH · Form: 8-K · Filed: Jan 14, 2025 · CIK: 1083446

Astrana Health, INC. 8-K Filing Summary
FieldDetail
CompanyAstrana Health, INC. (ASTH)
Form Type8-K
Filed DateJan 14, 2025
Risk Levellow
Pages3
Reading Time3 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: disclosure, financials

TL;DR

Astrana Health dropped an 8-K on Jan 14th - check it for Reg FD and financials.

AI Summary

Astrana Health, Inc. filed an 8-K on January 14, 2025, reporting on Regulation FD disclosures and financial statements. The company, formerly known as Apollo Medical Holdings, Inc., is incorporated in Delaware and headquartered in Alhambra, California.

Why It Matters

This filing provides important updates and disclosures regarding Astrana Health's financial status and regulatory compliance, which are crucial for investors to assess the company's performance and outlook.

Risk Assessment

Risk Level: low — This is a routine 8-K filing for disclosures and exhibits, not indicating any immediate operational or financial distress.

Key Players & Entities

FAQ

What specific Regulation FD disclosures are being made in this 8-K filing?

The filing indicates that Regulation FD disclosures are being reported, but the specific details of these disclosures are not provided in the provided text excerpt.

What are the key financial statements and exhibits included with this 8-K?

The filing states that 'Financial Statements and Exhibits' are included, but the specific content of these documents is not detailed in the provided excerpt.

When was Astrana Health, Inc. previously known as Apollo Medical Holdings, Inc.?

The filing indicates a name change from Apollo Medical Holdings, Inc. to Astrana Health, Inc. on July 15, 2008.

What is Astrana Health, Inc.'s principal executive office address?

Astrana Health, Inc.'s principal executive offices are located at 1668 S. Garfield Avenue, 2nd Floor, Alhambra, California 91801.

What is the Commission File Number for Astrana Health, Inc.?

The Commission File Number for Astrana Health, Inc. is 001-37392.

Filing Stats: 858 words · 3 min read · ~3 pages · Grade level 11.7 · Accepted 2025-01-14 08:00:17

Key Financial Figures

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On January 14, 2025, Astrana Health, Inc. (the "Company") updated its corporate presentation that it intends to use in connection with presentations at conferences and meetings. The slides from the Company's corporate presentation are attached as Exhibit 99.1 to this Current Report on Form 8-K and are incorporated herein by reference. The Company does not undertake to update the information contained in the attached presentation materials. The Company previously entered into an Asset and Equity Purchase Agreement to acquire certain businesses and assets of Prospect Medical Holdings, Inc. ("Prospect Medical"). On January 11, 2025, Prospect Medical filed for bankruptcy under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Northern District of Texas. The businesses and assets of Prospect Medical being acquired by the Company are not included in the bankruptcy filing, and the Company expects that such businesses and assets and the timing of the proposed acquisition will not be impacted by the bankruptcy filing. The information contained in this Current Report on Form 8-K, including the exhibit referenced herein, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing. The furnishing of this information will not be deemed an admission as to the materiality of any information contained herein.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Investor Presentation (January 2025). 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. These statements include words such as "forecast," "guidance," "projects," "estimates," "anticipates," "believes," "expects," "intends," "may," "plans," "seeks," "should," or "will," or the negative of these words or similar words. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in each such statement. A number of important factors could cause actual results to differ materially from those included within or contemplated by the forward-looking statements, including, but not limited to, the bankruptcy filing made by Prospect Medical, the factors described in the Company's filings with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the year ended December 31, 2023 and subsequent quarterly reports on Form 10-Q. The Company does not undertake any responsibility to update any of these factors or to announce publicly any revisions to any of the forward-looking statements contained in this or any other document, whether as a result of new information, future events, or otherwise.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASTRANA HEALTH, INC. Date: January 14, 2025 By: /s/ Brandon K. Sim Name: Brandon K. Sim Title: Chief Executive Officer and President

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing